Reference
Health Canada. Summary Safety Review - YERVOY (ipilimumab) - Posterior Reversible Encephalopathy Syndrome (PRES). Internet Document : 1 Dec 2014. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/yervoy-eng.php
Rights and permissions
About this article
Cite this article
Ipilimumab-associated encephalopathy?. Reactions Weekly 1531, 4 (2014). https://doi.org/10.1007/s40278-014-5637-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-5637-1